Skip to main content

Table 3 Clinical safety outcome measures

From: Software-guided versus nurse-directed blood glucose control in critically ill patients: the LOGIC-2 multicenter randomized controlled clinical trial

  Nurse-C LOGIC-C P value
Patients 773 777  
Length of ICU stay, median (IQR), days 3 (2–6) 3 (2–6) 0.39
Length of hospital stay, median (IQR), days 12 (8–23) 12 (8–23) 0.18
Mortality in the ICU, n (%) 41 (5.30) 47 (6.05) 0.61
Mortality in the hospital, n (%) 84 (10.81) 72 (9.31) 0.35
Mortality at 90 days, n (%) 89 (11.71) 91 (11.51) 0.93
Incidence of new infections in the ICU, n (%) 117 (15.14) 104 (13.38) 0.35
Ventilator days, median (IQR), days 1 (1–2) 1 (1–3) 0.85
EQ-5D index value at ICU discharge, median (IQR) 0.28 (0.13–0.58) 0.29 (0.13–0.58) 0.59
EQ-5D index value at 90 days, median (IQR) 0.73 (0.56–1) 0.73 (0.56–1) 0.58
EQ-5D VAS score at ICU discharge, median (IQR) 0.60 (0.50–0.70) 0.60 (0.50–0.70) 0.42
EQ-5D VAS score at 90 days, median (IQR) 0.70 (0.60–0.80) 0.70 (0.60–0.80) 0.97
  1. Data are mean (SD), median (IQR) or n (%). LOGIC-C patients randomized to algorithm-guided blood glucose control, Nurse-C patients randomized to blood glucose control by trained nurses, EQ-5D Euroqol-5D, VAS visual analog scale